Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
August 14, 2020
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Luca Gobbi, Julian Kretz, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells
Thais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
Journal of Medicinal Chemistry
|
July 11, 2024
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB<sub>1</sub>R)
Leonard Mach, Anahid Omran, Jara Bouma, et al.
Journal of the American Chemical Society
|
February 9, 2018
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB<sub>2</sub> Receptor Expression and Ligand Engagement in Human Cells
Marjolein Soethoudt, Sara C Stolze, Matthias V Westphal, et al.
Angewandte Chemie (International Ed. in English)
|
February 7, 2025
A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
European Journal of Medicinal Chemistry
|
September 22, 2022
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
Yingfang He, Uwe Grether, Marco F Taddio, et al.
Frontiers in Pharmacology
|
April 24, 2025
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay
Leire Borrega-Roman, Bradley L Hoare, Miroslav Kosar, et al.
Theranostics
|
December 8, 2025
Translational molecular imaging and drug development in multiple sclerosis
Daniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
ACS Central Science
|
May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C Sarott, David A Sykes, et al.
Nature Communications
|
November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization
David F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
August 14, 2020
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Luca Gobbi, Julian Kretz, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells
Thais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
Journal of Medicinal Chemistry
|
July 11, 2024
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB<sub>1</sub>R)
Leonard Mach, Anahid Omran, Jara Bouma, et al.
Journal of the American Chemical Society
|
February 9, 2018
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB<sub>2</sub> Receptor Expression and Ligand Engagement in Human Cells
Marjolein Soethoudt, Sara C Stolze, Matthias V Westphal, et al.
Angewandte Chemie (International Ed. in English)
|
February 7, 2025
A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
European Journal of Medicinal Chemistry
|
September 22, 2022
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
Yingfang He, Uwe Grether, Marco F Taddio, et al.
Frontiers in Pharmacology
|
April 24, 2025
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay
Leire Borrega-Roman, Bradley L Hoare, Miroslav Kosar, et al.
Theranostics
|
December 8, 2025
Translational molecular imaging and drug development in multiple sclerosis
Daniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
ACS Central Science
|
May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C Sarott, David A Sykes, et al.
Nature Communications
|
November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization
David F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Page
of 10